# National Medical Products Administration

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/national-medical-products-administration/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 36.2 |
| Citations | 187,698 |
| City | Beijing |
| Country | CN |
| Description | National Medical Products Administration is a research organisation in Beijing, CN. OpenAlex records 4,826 works and 187,698 citations for it. 2,875 researchers list it as their most recent affiliation. |
| Homepage | http://english.nmpa.gov.cn/ |
| OpenAlex ID | https://openalex.org/I223893228 |
| Region | Beijing |
| Researchers | 2,875 |
| ROR ID | https://ror.org/002k3wk88 |
| Type | government |
| Wikidata ID | Q50839285 |
| Works | 4,826 |

## University papers

Showing 12 of 58.

- [CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells](https://scholariq.org/papers/cd147-spike-protein-is-a-novel-route-for-sars-cov-2-infection-to-host-cells/)
- [Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis](https://scholariq.org/papers/breast-cancer-secreted-mir-122-reprograms-glucose-metabolism-in-premetastatic/)
- [Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis](https://scholariq.org/papers/abrogation-of-tgf-signaling-in-mammary-carcinomas-recruits-gr-1-cd11b-myeloid/)
- [SARS-CoV-2 invades host cells via a novel route: CD147-spike protein](https://scholariq.org/papers/sars-cov-2-invades-host-cells-via-a-novel-route-cd147-spike-protein/)
- [Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer](https://scholariq.org/papers/myeloid-derived-suppressor-cells-suppress-antitumor-immune-responses-through-ido/)
- [Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/camrelizumab-plus-carboplatin-and-pemetrexed-versus-chemotherapy-alone-in/)
- [Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells](https://scholariq.org/papers/cancer-cell-secreted-exosomal-mir-105-promotes-tumour-growth-through-the-myc/)
- [Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer](https://scholariq.org/papers/effect-of-first-line-serplulimab-vs-placebo-added-to-chemotherapy-on-survival-in/)
- [Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)](https://scholariq.org/papers/efficacy-and-safety-of-sintilimab-plus-pemetrexed-and-platinum-as-first-line/)
- [Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting](https://scholariq.org/papers/small-babies-big-risks-global-estimates-of-prevalence-and-mortality-for/)
- [HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma](https://scholariq.org/papers/hdac-inhibitors-enhance-t-cell-chemokine-expression-and-augment-response-to-pd-1/)
- [Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB](https://scholariq.org/papers/macrophage-immunomodulation-by-breast-cancer-derived-exosomes-requires-toll-like/)

## University researchers

- [Xiubao Ren](https://scholariq.org/researchers/xiubao-ren/)
- [Yue Cheng](https://scholariq.org/researchers/yue-cheng/)
- [Changning Sun](https://scholariq.org/researchers/changning-sun/)
- [Jinyan Feng](https://scholariq.org/researchers/jinyan-feng/)
- [Xiuxin Han](https://scholariq.org/researchers/xiuxin-han/)

## University top topics

Showing 8 of 25.

- [Traditional Chinese Medicine Analysis](https://scholariq.org/topics/traditional-chinese-medicine-analysis/)
- [Traditional Chinese Medicine Studies](https://scholariq.org/topics/traditional-chinese-medicine-studies/)
- [Biomedical Ethics and Regulation](https://scholariq.org/topics/biomedical-ethics-and-regulation/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Analytical Chemistry and Chromatography](https://scholariq.org/topics/analytical-chemistry-and-chromatography/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Pharmacological Effects of Natural Compounds](https://scholariq.org/topics/pharmacological-effects-of-natural-compounds/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.